From Advanced Eye Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
From Advanced Eye Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
J Cataract Refract Surg. 2017 Oct;43(10):1263-1270. doi: 10.1016/j.jcrs.2017.07.032.
To compare the demarcation line depth after contact lens-assisted corneal crosslinking (CXL) for progressive keratoconus using dextran-based and hydroxypropyl methylcellulose (HPMC)-based riboflavin solutions.
Advanced Eye Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Retrospective case series.
Patients with preoperative epithelium-on (epi-on) minimum corneal thickness between 350 μm and 450 μm having contact lens-assisted CXL for progressive keratoconus were crosslinked with isoosmolar 0.1% riboflavin in 20% dextran 500 or HPMC 1.1%. The primary outcome measure was the mean demarcation line depth measured 1 month postoperatively on anterior-segment optical coherence tomography. The secondary outcome measure was change in endothelial cell density (ECD) 6 months from baseline.
The study comprised 21 patients (21 eyes, 9 in the HPMC group and 12 in the dextran group). The mean demarcation line depth was deeper in the HPMC group (308.22 μm ± 84.19 [SD]) than in the dextran group (235.33 ± 64.87 μm) (P < .04). This difference remained significant (P = .02) even after controlling for the preoperative lesser epi-on minimum corneal thickness in the HPMC group (385.56 ±13.81 μm) versus the dextran group (413.08 ± 29.58 μm) (P < .02). The ECD 6 months after contact lens-assisted CXL was comparable to the baseline levels in both groups (P = .19 and P = .09, respectively).
During contact lens-assisted CXL, HPMC-based riboflavin seemed to be associated with a deeper demarcation line than dextran-based riboflavin, although both solutions were safe for the endothelium at 6 months.
比较使用基于葡聚糖和羟丙基甲基纤维素(HPMC)的核黄素溶液行接触镜辅助角膜交联术(CXL)治疗进行性圆锥角膜后角膜划线的深度。
印度昌迪加尔,医学教育与研究研究生学院高级眼科中心。
回顾性病例系列。
术前上皮下(epi-on)最小角膜厚度为 350μm 至 450μm 的行接触镜辅助 CXL 治疗进行性圆锥角膜的患者,使用等渗 0.1%核黄素交联液,交联液成分为 20%葡聚糖 500 或 HPMC 1.1%。主要结局指标为术后 1 个月前节光学相干断层扫描(OCT)测量的平均划线深度。次要结局指标为从基线开始 6 个月时内皮细胞密度(ECD)的变化。
本研究纳入 21 例患者(21 只眼,HPMC 组 9 例,葡聚糖组 12 例)。HPMC 组划线深度较深(308.22μm±84.19[标准差]),葡聚糖组(235.33μm±64.87μm)(P<.04)。即使在控制 HPMC 组术前上皮下最小角膜厚度(385.56μm±13.81μm)较葡聚糖组(413.08μm±29.58μm)(P<.02)的情况下,差异仍有统计学意义(P=0.02)。两组接触镜辅助 CXL 术后 6 个月 ECD 与基线水平相当(P=0.19 和 P=0.09)。
在接触镜辅助 CXL 过程中,与基于葡聚糖的核黄素相比,基于 HPMC 的核黄素似乎与更深的划线深度相关,但两种溶液在 6 个月时对内皮细胞均安全。